StonvexLoading…
StonvexStonvexStonvexCore line items from TRNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.14M | $11.53M | $7.39M | $2.58M |
Operating Income | $-3.99M | $-19.86M | $-18.16M | $-12.13M |
Net Income | $-10.74M | $-23.97M | $-5.23M | $-2.18M |
EPS (Diluted) | $-10.24 | $-171.77 | $-13.56 | $-12.49 |
Total Assets | $60.64M | $46.84M | $85.44M | $86.24M |
Total Liabilities | $52.67M | $38.15M | $67.98M | $69.97M |
Cash & Equivalents | $4.74M | $512.00K | $845.00K | $582.00K |
Free Cash Flow OCF − CapEx | $-2.68M | $-10.50M | Not available | Not available |
Shares Outstanding | 2.06M | 307.52K | 2.08M | 1.41M |